{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:20:39Z","timestamp":1788236439975,"version":"build-2803163510"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["2021R1I1A3056261"],"award-info":[{"award-number":["2021R1I1A3056261"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003715","name":"KRIBB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007334","name":"Ministry of Health and Family Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004541","name":"Ministry of Education, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.taap.2026.117868","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T22:46:38Z","timestamp":1778712398000},"page":"117868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Gut microbiome-related tryptophan metabolites modulate drug transporters, with prominent effects on OAT1 and OAT3"],"prefix":"10.1016","volume":"513","author":[{"given":"Min-Ji","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyeong-Ryoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Ju","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon-Cheol","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon-Jee","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2026.117868_bb0005","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1039\/D3AY01959D","article-title":"Analysis of tryptophan metabolites and related compounds in human and murine tissue: development and validation of a quantitative and semi-quantitative method using high resolution mass spectrometry","volume":"16","author":"Abujrais","year":"2024","journal-title":"Anal. Methods"},{"key":"10.1016\/j.taap.2026.117868_bb0010","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1177\/0884533615609896","article-title":"Role of the gut microbiome in obesity and diabetes mellitus","volume":"30","author":"Barlow","year":"2015","journal-title":"Nutr. Clin. Pract."},{"key":"10.1016\/j.taap.2026.117868_bb0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pharmthera.2012.07.010","article-title":"Drug transport by organic anion transporters (OATs)","volume":"136","author":"Burckhardt","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2026.117868_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejps.2016.09.012","article-title":"Feasibility of the functional expression of the human organic anion transporting polypeptide 1B1 (OATP1B1) and its genetic variant 521T\/C in the mouse liver","volume":"96","author":"Chae","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.taap.2026.117868_bb0025","doi-asserted-by":"crossref","DOI":"10.1007\/s40005-021-00538-8","article-title":"Regulation of drug transporters by microRNA and implications in disease treatment","volume":"52","author":"Chae","year":"2022","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.taap.2026.117868_bb0030","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/jpet.107.123554","article-title":"Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family","volume":"322","author":"Chen","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2026.117868_bb0035","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.trsl.2012.05.003","article-title":"The human gut microbiome: current knowledge, challenges, and future directions","volume":"160","author":"Dave","year":"2012","journal-title":"Transl. Res."},{"key":"10.1016\/j.taap.2026.117868_bb0040","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1124\/dmd.109.026880","article-title":"Novobiocin is a potent inhibitor for human organic anion transporters","volume":"37","author":"Duan","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2026.117868_bb0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuropharm.2016.05.020","article-title":"The kynurenine pathway in schizophrenia and bipolar disorder","volume":"112","author":"Erhardt","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2026.117868_bb0050","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.scitotenv.2018.01.288","article-title":"The impact of human activities and lifestyles on the interlinked microbiota and health of humans and of ecosystems","volume":"627","author":"Flandroy","year":"2018","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.taap.2026.117868_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100575","article-title":"Coordinate regulation of systemic and kidney tryptophan metabolism by the drug transporters OAT1 and OAT3","volume":"296","author":"Granados","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2026.117868_bb0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s40005-022-00600-z","article-title":"A mechanism-based understanding of altered drug pharmacokinetics by gut microbiota","volume":"53","author":"Gulnaz","year":"2023","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.taap.2026.117868_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12050468","article-title":"Pharmacokinetic interaction between metformin and verapamil in rats: inhibition of the OCT2-mediated renal excretion of metformin by verapamil","volume":"12","author":"Han","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.taap.2026.117868_bb0070","doi-asserted-by":"crossref","DOI":"10.1097\/IMNA-D-25-00026","article-title":"Targeting gut microbiota as a promising therapy for chronic kidney disease","volume":"12","author":"He","year":"2025","journal-title":"Integr. Med. Nephrol. Androl."},{"key":"10.1016\/j.taap.2026.117868_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0258505","article-title":"The importance of age in compositional and functional profiling of the human intestinal microbiome","volume":"16","author":"Herzog","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2026.117868_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110886","article-title":"Pharmacokinetic interactions of niclosamide in rats: involvement of organic anion transporters 1 and 3 and organic cation transporter 2","volume":"390","author":"Kang","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2026.117868_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117114","article-title":"Interactions of bosutinib with drug transporters: in vitro and in vivo inhibition of organic cation transporter 2, multidrug and toxin extrusion protein 1, and breast cancer resistance protein by bosutinib","volume":"178","author":"Kang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2026.117868_bb0090","first-page":"1","article-title":"Identification of flavonol derivatives inhibiting MDR1: A strategy to overcome multidrug resistance in cancer","author":"Kang","year":"2024","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.taap.2026.117868_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13010083","article-title":"Involvement of organic anion transporters in the pharmacokinetics and drug interaction of Rosmarinic acid","volume":"13","author":"Kang","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.taap.2026.117868_bb0100","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","article-title":"The microbiome in inflammatory bowel disease: current status and the future ahead","volume":"146","author":"Kostic","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.taap.2026.117868_bb0105","first-page":"1347","article-title":"Sensitive and valid assay for reliable evaluation of drug interactions mediated by human organic anion transporter 1 and 3 using 5-carboxyfluorescein","volume":"38","author":"Lee","year":"2022","journal-title":"Anal. Sci. Int. J. Japan Soc. Anal. Chem."},{"key":"10.1016\/j.taap.2026.117868_bb0110","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/ajcn\/nqac170","article-title":"Associations between plasma tryptophan and indole-3-propionic acid levels and mortality in patients with coronary artery disease","volume":"116","author":"Li","year":"2022","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.taap.2026.117868_bb0115","article-title":"Gut microbiota and renal fibrosis: novel mechanistic insights and therapeutic potential","author":"Liu","year":"2026","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.taap.2026.117868_bb0120","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein\u2013ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.taap.2026.117868_bb0125","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41392-024-01743-1","article-title":"Microbiota\u2013gut\u2013brain axis and its therapeutic applications in neurodegenerative diseases","volume":"9","author":"Loh","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.taap.2026.117868_bb0130","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3389\/fphar.2020.00802","article-title":"Identification of structural features for the inhibition of OAT3-mediated uptake of enalaprilat by selected drugs and flavonoids","volume":"11","author":"Ni","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.117868_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215303","article-title":"Protein abundance of clinically relevant drug transporters in the human kidneys","volume":"20","author":"Oswald","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.taap.2026.117868_bb0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4137\/IJTR.S2129","article-title":"L-tryptophan: basic metabolic functions, behavioral research and therapeutic indications","volume":"2","author":"Richard","year":"2009","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.taap.2026.117868_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms7010014","article-title":"What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases","volume":"7","author":"Rinninella","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.taap.2026.117868_bb0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","article-title":"Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation","volume":"7","author":"Romano","year":"2021","journal-title":"Npj Park. Dis."},{"key":"10.1016\/j.taap.2026.117868_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020542","article-title":"Interplay of breast cancer resistance protein (Bcrp\/Abcg2), sex, and fed state in oral pharmacokinetic variability of Furosemide in rats","volume":"15","author":"Sharma","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.taap.2026.117868_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110504","article-title":"Strong inhibition of organic cation transporter 2 by flavonoids and attenuation effects on cisplatin-induced cytotoxicity","volume":"379","author":"Shin","year":"2023","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2026.117868_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fendo.2020.00025","article-title":"The role of short-chain fatty acids from gut microbiota in gut-brain communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.taap.2026.117868_bb0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/jpet.118.250225","article-title":"Suppression of canine ATP binding cassette ABCB1 in Madin-Darby canine kidney type II cells unmasks human ABCG2-mediated efflux of Olaparib","volume":"368","author":"Song","year":"2019","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2026.117868_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106177","article-title":"Role of the efflux transporters Abcb1 and Abcg2 in the brain distribution of olaparib in mice","volume":"173","author":"Song","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.taap.2026.117868_bb0180","series-title":"drug Transp. Mol. Charact. Role Drug Dispos.","first-page":"79","article-title":"Organic anion transporting polypeptides OATP","author":"Tirona","year":"2022"},{"key":"10.1016\/j.taap.2026.117868_bb0185","first-page":"1","article-title":"What defines a healthy gut microbiome?","author":"Van Hul","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.taap.2026.117868_bb0190","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/JLB.3RI0620-405RR","article-title":"Age-related changes in intestinal immunity and the microbiome","volume":"109","author":"Walrath","year":"2021","journal-title":"J. Leucoc. Biol."},{"key":"10.1016\/j.taap.2026.117868_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035556","article-title":"Male-dominant activation of rat renal organic anion transporter 1 (Oat1) and 3 (Oat3) expression by transcription factor BCL6","volume":"7","author":"Wegner","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2026.117868_bb0200","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1073\/pnas.0812874106","article-title":"Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites","volume":"106","author":"Wikoff","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.taap.2026.117868_bb0205","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.chom.2017.06.007","article-title":"Indoleacrylic acid produced by commensal Peptostreptococcus species suppresses inflammation","volume":"22","author":"Wlodarska","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.taap.2026.117868_bb0210","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.taap.2026.117868_bb0215","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41435-023-00235-6","article-title":"AHR and tryptophan metabolism: a collaborative dynamics of immune regulation","volume":"25","author":"Zhu","year":"2024","journal-title":"Genes Immun."},{"key":"10.1016\/j.taap.2026.117868_bb0220","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1007\/s12264-021-00730-8","article-title":"The relationship between the gut microbiome and neurodegenerative diseases","volume":"37","author":"Zhu","year":"2021","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.taap.2026.117868_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.746208","article-title":"Drug transporters in the kidney: perspectives on species differences, disease status, and molecular docking","volume":"12","author":"Zou","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2600164X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2600164X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T04:02:20Z","timestamp":1788235340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X2600164X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"alternative-id":["S0041008X2600164X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.117868","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiome-related tryptophan metabolites modulate drug transporters, with prominent effects on OAT1 and OAT3","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.117868","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117868"}}